Showing 1 - 20 results of 61 for search '(( significantly marked decrease ) OR ( significantly less decrease ))~', query time: 0.51s Refine Results
  1. 1
  2. 2

    S1 File - by Ingmar Lundquist (46422)

    Published 2025
    “…Culturing at high glucose increased both nNOS and iNOS activities inducing a marked decrease in GSIS in a following short-term incubation at high glucose. …”
  3. 3
  4. 4
  5. 5

    ROC analysis to mark selectivity results in mostly mixed-selective units. by Thomas S. Wierda (22404198)

    Published 2025
    “…The large number of mixed selective units also results in a significant decrease in accuracy when these neurons are targeted as compared to <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013559#pcbi.1013559.g006" target="_blank">Fig 6c</a> where there was no significant effect visible after targeting mixed selective units, likely because there were less mixed selective units present. …”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    S1 Data - by Jan Willem Koten (17743224)

    Published 2024
    “…The mean connectivity decreased to r = 0.09 (95% CI 0.03–0.16) when test-retest reliability and auto-correlations of single time courses were considered, indicating that less than a quarter of connectivity is detectable. …”
  13. 13

    Connectivity statistics. by Jan Willem Koten (17743224)

    Published 2024
    “…The mean connectivity decreased to r = 0.09 (95% CI 0.03–0.16) when test-retest reliability and auto-correlations of single time courses were considered, indicating that less than a quarter of connectivity is detectable. …”
  14. 14

    Baseline characteristics of the participants. by Junichi Kushioka (12236447)

    Published 2024
    “…Our accessible, non-invasive model serves as a tool that can accurately diagnose the labor-intensive LS tests using only visual assessments, streamlining LS detection and expediting treatment initiation. This significantly improves patient outcomes and marks a crucial advancement in digital health, addressing key challenges in management and care of LS.…”
  15. 15

    Internal validation by cross-validation. by Junichi Kushioka (12236447)

    Published 2024
    “…Our accessible, non-invasive model serves as a tool that can accurately diagnose the labor-intensive LS tests using only visual assessments, streamlining LS detection and expediting treatment initiation. This significantly improves patient outcomes and marks a crucial advancement in digital health, addressing key challenges in management and care of LS.…”
  16. 16

    Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

    Published 2024
    “…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”
  17. 17

    Supporting information. by Maedehsadat Seyedalangi (22655973)

    Published 2025
    “…Antioxidant activities (DPPH, ABTS, and FRAP) were markedly higher in treated samples, as DPPH values changed only slightly (from 4.20 to 5.23) compared to the control (from 10.91 to 36.41), and FRAP activity decreased less sharply (35.88 to 25.30 vs. 20.01 to 11.75). …”
  18. 18
  19. 19
  20. 20